Sayna Norouzi, MD
LightNews LightNews
banner
saynanorouzi.bsky.social
Sayna Norouzi, MD
@saynanorouzi.bsky.social
730 followers 58 following 65 posts
Academic Nephrologist|Director @GlomCon fellowship|Director👩🏼‍⚕️Glomerular Disease & PKD Clinics👠📟
Posts Replies Media Videos
Reposted by Sayna Norouzi, MD
alexchangmd.bsky.social
Excellent Rare Kidney Disease Conference hosted by Loma Linda at the historic Mission Inn led by @saynanorouzi.bsky.social great case discussions on IgA nephropathy, c3G, PKd, genetic testing and galore! Enjoyed the AI discussant as an additional panelist, and Dr Glassock taking down AI bots
December 7, 2025 at 10:11 PM
saynanorouzi.bsky.social
Exploring the Role of Plant-Based Nutrition in Polycystic Kidney Disease

pubmed.ncbi.nlm.nih.gov/41305569/
Exploring the Role of Plant-Based Nutrition in Polycystic Kidney Disease - PubMed
Polycystic kidney disease (PKD) is a genetic disorder characterized by progressive kidney cyst formation and eventual kidney failure. Emerging evidence suggests that plant-based diets may confer therapeutic benefits in patients with PKD by modulating mTOR and AMPK signaling, reducing oxidative stres …
pubmed.ncbi.nlm.nih.gov
November 29, 2025 at 9:20 PM
Reposted by Sayna Norouzi, MD
edgarvlermamd.bsky.social
Is It Time to Consider Population-Based Urine Dipstick Screening for Early Detection of Kidney Disease? ca. 2025 from @kireports.bsky.social @saynanorouzi.bsky.social
#Nephpearls #KidneyWk #NephSky

👉 www.kireports.org/article/S246...
November 7, 2025 at 2:58 PM
Reposted by Sayna Norouzi, MD
izabelazakrocka.bsky.social
Great start of ‚Hot topics in lupus nephritis’ session chaired by @saynanorouzi.bsky.social and Juan M. Mejia-Vilet, with an excellent lecture of @kronbichlerlab.bsky.social on 25’ treatment targets #KidneyWk @asnkidney.bsky.social
November 7, 2025 at 11:44 PM
saynanorouzi.bsky.social
🔥 Brilliant session by the legendary Dr. Glassock at the #GlomCon Fellowship!

Limiting #LupusNephritis flares is JUST as important as treatment.
✅ Prevent relapses → ↓ risk of #ESKD
🎯 Goal: Immunological remission (normal complements, neg. anti-dsDNA)

@glomcon.org
October 30, 2025 at 6:10 PM
saynanorouzi.bsky.social
📟Do female nephrologists feel as supported as their male colleagues? Do they face the same challenges?
For the first time, our study compares the perspectives of female and male nephrologists; exploring differences in perceived support and professional obstacles.
@asnkidney.bsky.social
October 30, 2025 at 5:50 PM
Reposted by Sayna Norouzi, MD
edgarvlermamd.bsky.social
Empowering the Next Generation of Nephrologists: Trainee Opportunities in #GlomCon Ecosystem from @asnpublications.bsky.social @glomcon.org @bettercallseeth.bsky.social @saynanorouzi.bsky.social @nephrologista.bsky.social @poyanmehr.org
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41105470/
October 18, 2025 at 3:09 PM
Reposted by Sayna Norouzi, MD
edgarvlermamd.bsky.social
IgA Nephropathy #IgAN: An Overview of the Clinical Trials ca. 2025 from @kidneymed.bsky.social @alexgr23.bsky.social @saynanorouzi.bsky.social
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41050133/
October 6, 2025 at 5:10 PM
saynanorouzi.bsky.social
Huge thank you to our incredible faculty, attendees, sponsors, and GlomCon instructors for making #GlomConHawaii conference a success! 🌟
We deeply appreciate and value your partnership.
Hope to see you all next year, in Maui August 3-7 ⭐️

Mahalo!! 🌺
@glomcon.org
September 29, 2025 at 7:42 PM
saynanorouzi.bsky.social
Huge thank you to our incredible faculty, attendees, sponsors, and GlomCon instructors for making #GlomConHawaii conference a success! 🌟
We deeply appreciate and value your partnership.
Hope to see you all next year, in Maui August 3-7 ⭐️

Mahalo!! 🌺
September 29, 2025 at 7:40 PM
saynanorouzi.bsky.social
What a fantastic evening at the #GlomConHawaii reception! Thank you to everyone who joined us🥰
It’s a privilege to be part of such an exceptional community. The future of nephrology is bright. @glomcon.org
September 24, 2025 at 10:11 PM
Reposted by Sayna Norouzi, MD
hswapnil.medsky.social
Excellent thread below

I will also plug this talk by Paola Romagnani on podocytopathies

youtu.be/bRMeqaGgA9I?...

#GlomCon #NephGR
September 24, 2025 at 12:00 AM
Reposted by Sayna Norouzi, MD
glomcon.org
Register here 👉 glomconhawaii.org

#GlomConHawaii2025
#GlomConHawaii
#GlomCon
Home | GlomCon Hawaii
GlomCon Hawaii is an annual in-person and hybrid conference dedicated to advancing education, research, and collaboration in nephrology. As part of GlomCon Foundation's initiative, the conference brin...
glomconhawaii.org
May 15, 2025 at 8:02 PM
Reposted by Sayna Norouzi, MD
glomcon.org
This year’s in-person gathering promises to strengthen connections, spark deeper collaboration, and elevate the learning experience in beautiful Hawaii.

Can't join us in person? We plan to live-stream the main sessions; see you on the virtual side.

#GlomConHawaii
#GlomCon
glomcon Event
Enjoy the event with us!
bit.ly
February 25, 2025 at 3:08 PM
Reposted by Sayna Norouzi, MD
edgarvlermamd.bsky.social
Clinical Endpoints for Glomerular Diseases from
@hjanders.bsky.social
#GlomConHawaii 🌊 #Nephpearls #NephSky
September 22, 2025 at 9:04 PM
Reposted by Sayna Norouzi, MD
edgarvlermamd.bsky.social
IgA Nephropathy #IgAN: An Overview of the Clinical Trials ca. 2025 from @saynanorouzi.bsky.social
#Nephpearls #NephSky

www.kidneymedicinejournal.org/article/S259...
IgA Nephropathy: An Overview of the Clinical Trials
IgA nephropathy (IgAN) is characterized by the deposition of poorly-O-galactosylated IgA1 (also referred to as galactose-deficient IgA1 or gd-IgA1) containing immune complexes in the glomerular mesang...
www.kidneymedicinejournal.org
August 7, 2025 at 12:35 PM
Reposted by Sayna Norouzi, MD
hswapnil.medsky.social
Congrats @sophia-kidney.bsky.social @saynanorouzi.bsky.social @kashvilunawat.bsky.social

And all the other awardees of the @asnkidney.bsky.social NephCure grants!

www.kidneycure.org/pages/qa.aspx
KidneyCure | Spotlights/Q&A - Who We Fund
Learn more about who KidneyCure funds.
www.kidneycure.org
July 2, 2025 at 10:25 AM
Reposted by Sayna Norouzi, MD
hswapnil.medsky.social
It’s not just the immune mediated and infections - we need to pay attention to cardiovascular disease in SLE

pubmed.ncbi.nlm.nih.gov/40539000/

Nice job synthesizing the data @saynanorouzi.bsky.social and team!

#NephSky #lupuschat
Cardiovascular Events in Lupus Nephritis: A Systematic Review and Meta-Analysis - PubMed
CVE occurrence among individuals with LN is significant, and this disease entity increases CVE risk, highlighting the importance of implementing early therapeutic interventions to prevent poor outcome...
pubmed.ncbi.nlm.nih.gov
June 21, 2025 at 2:27 PM
Reposted by Sayna Norouzi, MD
glomcon.org
#GlomConHawaii 2025 🌴🌊 session:
Post-market Evaluations, Registries, and RWE Studies

Register here 👉 glomconhawaii.org

#GlomConHawaii2025
#GlomConHawaii
#GlomCon
June 6, 2025 at 2:02 PM
Reposted by Sayna Norouzi, MD
izabelazakrocka.bsky.social
@saynanorouzi.bsky.social rocks in Vienna #ERA25! @glomcon.org
June 5, 2025 at 10:49 AM
Reposted by Sayna Norouzi, MD
glomcon.org
🚨 Exciting News! 🚨
The GlomCon Foundation, American Kidney Fund, and
IgA Nephropathy Foundation have joined forces to develop the consensus framework for establishing Centers of Excellence in Glomerular Disease Care!

🔗 Learn more: www.glomcon.org/news-release...
May 5, 2025 at 2:17 PM
Reposted by Sayna Norouzi, MD
glomcon.org
Applications are now open for the Polycystic Kidney Disease Medical Directorship Program (PKD-MDP)! 🤩

🔗 Apply here: www.glomcon.org/pkdmd-program
📅 Deadline to apply is July 15, 2025
May 1, 2025 at 3:29 PM
Reposted by Sayna Norouzi, MD
hcplivenews.bsky.social
Q1 was full of important advances in #nephrology, especially in glomerular diseases. Hear from @SaynaNorouzi @LLUHealth @GlomCon as she reflects on some of these developments and looks ahead to what might be in store for the rest of 2025:

www.hcplive.com/view...
What’s New and What’s Next in Glomerular Disease Care, with Sayna Norouzi, MD
Norouzi reflects on significant advances in glomerular disease from Q1 and looks ahead to what the rest of 2025 may have to offer.
www.hcplive.com
April 26, 2025 at 9:00 AM
Reposted by Sayna Norouzi, MD
saynanorouzi.bsky.social
Are you effectively preventing VTE in your patients with nephrotic syndrome?

Check out our paper below on KI reports about this important topic. It's a fantastic collaboration with some truly brilliant minds! #NephSky @glomcon.org

www.kireports.org/article/S246...
Venous thromboembolism prevention for nephrotic syndrome: The role of aspirin, vitamin K antagonists and direct oral anticoagulants
Nephrotic syndrome (NS) carries a significantly elevated risk of venous thromboembolic events (VTE), contributing to morbidity and mortality. Current guidelines for VTE prophylaxis in NS are based on ...
www.kireports.org
February 26, 2025 at 3:12 AM